Bracco (company)

Last updated
Bracco S.p.A.
Company type Private (family-owned)
IndustryChemical, pharmaceutical
Founded1927
FounderElio Bracco
Headquarters
Area served
Worldwide
Key people
Diana Bracco (President and CEO)
Productscontrast agents, injectors, medical devices, pharma
RevenueIncrease2.svg 1,300,000,000 [1]
Number of employees
3400 (2015)
Website www.bracco.com

The Bracco Group is an Italian multinational active in the healthcare sector with more than 3,300 employees worldwide, [2] which operates in a variety of business areas. [2]

Contents

Bracco has consolidated revenues of more than 1.1 billion euro, of which 75% from international sales. [3] The Group is present in 100 countries and invests approximately 10% of its core diagnostic imaging revenues in research and innovation. In Italy Bracco is also a brand associated with a number of historic pharmaceutical products such as Cebion, Xamamina, Euclorina, the Alfa eye-drops line and the Friliver range of sport supplements.

The Group Chairman and Chief Executive Officer is Diana Bracco. A chemistry graduate from the University of Pavia, Diana Bracco is also Chairman of Expo 2015 Spa, General Section Commissioner for the Italy Pavilion at Expo and Confindustria Vice President for Research & Innovation. Decorated as a Cavaliere del Lavoro, she was President of Assolombarda and, before that, Chairman of Federchimica. In February 2001 she received an Honorary Doctor of Pharmacy degree from University of Pavia. On January 12, 2015, Diana Bracco was "prosecuted on charges of tax evasion and embezzlement, crimes allegedly committed as chairman of the board of the pharmaceutical group Bracco Spa." [4] [5] [6] [7] In October 2016, she was given a two year suspended sentence for tax fraud and embezzlement. [8]

As of 2020, the group has a consolidated turnover of approximately 1.4 billion euros, of which 89% on foreign markets. It is present in 100 countries with 3,587 employees. [9] The Bracco group has 1,800 patents, 7 research and development centers and 9 factories worldwide. [10]

History

The company founded by Elio Bracco was established in 1927 in Milan with the name Società Italiana Prodotti E Merck, to produce, package and sell the chemical products of the German company E. Merck. It had just five employees. In 1934 Fulvio Bracco, Elio's son, officially joined the company which, the same year, began marketing Cebion, an innovative product based on vitamin C, recently discovered by the Hungarian biochemist Albert Szent-Györgyi. In 1962 Bracco researchers created the first contrast agent based on their original research: iodamide, a product with very high tolerability. On 17 March 1977 Diana Bracco, Fulvio's daughter, was appointed Bracco General Manager.

In 1981 the company launched Iopamidol in Italy and Germany. In the second half of the 1980s, Bracco Spa became the leading international producer of non-ionic contrast agents. It also won a positive response and important results for other formulations, including the anti-tuberculosis drug pyrazinamide, of which Bracco is the leading world producer, which is included in the WHO list of essential pharmaceuticals.[ citation needed ]

In 1990, Bracco began a ten-year period of important growth. At international level, acquisitions and joint ventures enhanced the Group structure. In 1990 the Bracco Eisai joint venture was set up in Japan. In 1994 Bracco acquired Squibb Diagnostic, a company in the Bristol Myers Squibb group in the United States, which is still Bracco Imaging's largest market today. 1995 saw the integration of the three research centres in Milan, Geneva and Princeton: Milan focuses on the research and development of contrast agents for radiology and magnetic resonance, Bracco Research Geneva on ultrasound and Bracco Research USA Princeton on magnetic resonance and nuclear medicine.

1999 was a milestone year for the company: the Bracco family and the Merck Group reached an agreement under which Bracco bought Merck's 50% stake in the Group's diagnostic and pharmaceuticals operations. In 2001, the Bracco Group acquired ACIST Medical Systems, a US company based in Eden Prairie, Minnesota, a suburb of Minneapolis, active in advanced contrast-agent management and injection systems. Meanwhile, the Group's international growth continued, with more offices opening around the world. Since 2002 Bracco has had a direct presence in China with Bracco Sine Pharmaceutical Corp. Ltd. in Shanghai. In 2008 it acquired E-Z-EM, a leading company in the radiology sector. In 2010 Bracco entered Estonia, Scandinavia and South Korea. In 2011 Bracco Imaging acquired Swiss Medical Care (now Bracco Injeneering) and the Nycomed production plants in Singen (Germany). In 2012 it completed the acquisitions of Justesa in Argentina, Mexico and Brazil.

[11]

Gruppo Companies

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical Research and Manufacturers of America</span> Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.

<span class="mw-page-title-main">Merck Group</span> German multinational science and technology company

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

<span class="mw-page-title-main">GE HealthCare</span> American multinational medical technology company

GE HealthCare Technologies, Inc. is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from General Electric on January 4, 2023, with GE retaining 10.24%. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, XRAY; Ultrasound; Cath Labs; Mammogram; Nuclear Medicine Cameras; and develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries.

<span class="mw-page-title-main">Labcorp Drug Development</span> Contract research organization

Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.

<span class="mw-page-title-main">ItAli Airlines</span> Former Italian Airline based in Rome.

ItAli Airlines S.p.A. was an airline based in Rome. It operated regional scheduled, charter and cargo services, as well as air taxi flights. Its main base was Leonardo da Vinci-Fiumicino International Airport, Rome.

Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006. The company was founded as the Serono Pharmacological Institute by Cesare Serono in 1906 in Rome, Italy. A key step in its development was the discovery of a method of extracting urinary gonadotropins by Dr. Piero Donini. Serono was incorporated in 1987 and the holding company, Ares-Serono S.A., changed its name to Serono S.A. in May 2000.

<span class="mw-page-title-main">Zonisamide</span> Chemical compound

Zonisamide, sold under the brand name Zonegran among others, is a medication used to treat the symptoms of epilepsy and Parkinson's disease. Chemically it is a sulfonamide. It serves as an anticonvulsant used primarily as an adjunctive therapy in adults with Parkinson's disease, partial-onset seizures; infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic and generalized tonic clonic seizure. Despite this it is also sometimes used as a monotherapy for partial-onset seizures.

Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

<span class="mw-page-title-main">Zambon</span> Italian pharmaceutical company

Zambon is an Italian company that has been operating in the pharmaceutical and fine chemical industry since 1906. The company is currently run by Elena Zambon who is the daughter of the founder.

<span class="mw-page-title-main">Eribulin</span> Pharmaceutical drug

Eribulin, sold under the brand name Halaven among others, is an anti-cancer medication used to treat breast cancer and liposarcoma.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

<span class="mw-page-title-main">Piramal Group</span> Indian conglomerate

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.

<span class="mw-page-title-main">Santen Pharmaceutical</span>

Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.

The Global Health Innovative Technology Fund, headquartered in Japan, is an international public-private partnership between the Government of Japan, 16 pharmaceutical and diagnostics companies, the Bill & Melinda Gates Foundation, the Wellcome Trust and United Nations Development Programme. It funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. Bill Gates has noted that "GHIT draws on the immense innovation capacity of Japan’s pharmaceutical companies, universities and research institutions to accelerate the creation of new vaccines, drugs and diagnostic tools for global health." Margaret Chan, former Director-General of the World Health Organization, said: "The GHIT Fund has stepped in to provide that incentive in a pioneering model of partnership that brings Japanese innovation, investment and leadership to the global fight against infectious disease."

Esaote SpA is an Italian company operating in the biomedical sector that deals with the design, production, sale and maintenance of equipment for medical diagnostics.

Romano Volta is an Italian businessman who is the executive chairman and founder of Datalogic, an Italian company manufacturing barcode readers, mobile computers, radio-frequency identification, sensors for detection, and other electronic equipment.

<span class="mw-page-title-main">Gadopiclenol</span> MRI contrast agent

Gadopiclenol, sold under the brand name Elucirem among others, is a contrast agent used with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system and in the body. Gadopiclenol is a paramagnetic macrocyclic non-ionic complex of gadolinium.

References

  1. Bracco SpA, ed. (2012). "Financial Highlights" (in English and Italian). Archived from the original on 19 November 2012. Retrieved 14 February 2015.
  2. 1 2 Bracco SpA, ed. (2012). "Financial Highlights" (in English and Italian). Archived from the original on 19 November 2012. Retrieved 14 February 2013.
  3. Bracco SpA, ed. (2013). "Fatturato per Aree geografiche" (in English and Italian). Archived from the original on 13 February 2011. Retrieved 14 February 2013.
  4. "Evasione, "case e yacht ristrutturati con i soldi della società": Diana Bracco rinviata a giudizio a Milano - Repubblica.it" (in Italian). Repubblica.it. Retrieved 2016-01-12.
  5. F. Q. "Diana Bracco, a processo per evasione fiscale il vicepresidente di Confindustria - Il Fatto Quotidiano" (in Italian). Il Fatto Quotidiano. Retrieved 2016-01-12.
  6. Umberto Bacchi (May 29, 2015). "Expo Milano 2015 president Diana Bracco faces embezzlement and tax evasion probe". IBTimes Co., Ltd. Retrieved 2015-06-19.
  7. President of Milan Expo investigated for tax evasion, embezzlement May 29, 2015
  8. Ex-Confindustria VP gets two years for tax fraud, 19 October 2010 Agenzia Nazionale Stampa Associata, retrieved 15 April 2018
  9. "Il Gruppo". Bracco Corporate (in Italian). Retrieved 25 May 2017.
  10. "Bracco - Ultime notizie su Bracco - Argomenti del Sole 24 Ore". Argomenti Argomenti del Sole 24 Ore. Retrieved 25 May 2017.
  11. "From Neresine to Milan. Memories of the Italian Entrepreneur Fulvio Bracco" edited by Bracco Foundation, year 2012